Dr. Christensen is recognized worldwide as an expert in learning technology. He has pioneered adaptive learning, data-driven content development, simulation and debriefing technologies. He is responsible for the strategy of Area9 Group’s businesses, which span from purpose-built platforms for optimization of business processes for large corporations over digital product design to corporate training based on intelligent, adaptive learning. Founded his first company, Sophus Medical, in 1997 while still in medical school. Sophus Medical was acquired by Laerdal Medical in 2002.
Dr. Christensen co-founded Area9 Group in 2006, which has been at the forefront of adaptive and personalized learning. Area9 Education was sold to McGraw-Hill Education in 2014. Area9 Learning was then established to focus on adaptive learning in corporate and organizational environments. Dr. Christensen was part of the McGraw-Hill Higher Education leadership team from 2011 to 2014 and the Executive Leadership Team from 2014 to 2016.
Today, his primary focus is Area9 Lyceum which in January 2018 assembled all the group’s educational investments and technologies, and set out to create the 4th generation adaptive learning platform and the first generation supporting four dimensional education. In addition, he is the chairman of Altus Care and in 2017, Dr. Christensen was appointed expert-in-residence at the translational accelerator at Brigham and Women’s Hospital-Harvard Medical School. He is on the boards of LEAP Innovation, Mastery Transcript Consortium, as well as, the advisory board for Transcend Education, CharacterLab, Center for Curriculum Redesign at Harvard University and is also the co-chair of the advisory board in emergency medicine at Brigham and Women’s hospital in Boston.